Study to Confirm the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis
Status:
Completed
Trial end date:
2017-03-24
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm the efficacy of CJ-12420, Once daily (QD), compared
to esomeprazole in patients with erosive esophagitis classified as Los Angeles (LA)
classification grades A to D at Week 8.